The Neuromuscular group at Johns Hopkins has considerable clinical expertise in dealing with immunological disorders affecting the peripheral nerve system, neuromuscular junction and skeletal muscle. These disorders include Myesthenia Gravis, Guillain Barre syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Polymyositis, Dermatomyositis, Sarcoidosis and Vasculitic Neuropathies. In order to serve such patients, The Johns Hopkins Neurology Outpatient Center recently opened an intravenous infusion center so that immunomodulating therapies, such as intravenous immunoglobulin, could be administered to patients in a supervised setting, avoiding the necessity of inpatient admission. In addition to seeing patients in the Outpatient Clinic, faculty members in the Neuromuscular group have active immunological research programs. Particular areas of research focus include the pathogenesis of Guillain Barre Syndrome, and the design and testing of novel therapeutic agents in HIV-associated neuropathy and myasthenia gravis.

	The Richard T. Johnson Division of Neuroimmunology & Infectious Diseases The Johns Hopkins Hospital, Department of Neurology 600 N. Wolfe Street, Baltimore, MD 21287 443-287-4656 (tel)   410-502-8075 (fax)